HAYWARD, Calif., Oct. 13 /PRNewswire-FirstCall/ -- Solta Medical, Inc. (NASDAQ:SLTM), a global leader in the medical aesthetics market, today announced the appointment of Jeffrey C. Nardoci, as its Vice President of Global Marketing. Mr. Nardoci brings more than 19 years of experience in marketing and strategic consumer development in both the medical and consumer goods markets. At Solta Medical, he will focus on building the Company's brands, driving consumer awareness and developing marketing programs to enhance sales efforts. He will report to Clint Carnell, Chief Operating Officer of Solta Medical. "Jeff has a proven track record of generating sales and increasing market share at leading multinational corporations," said Mr. Carnell. "In his most recent position as Vice President of Commercial Operations, U.S. Vision Care with Bausch & Lomb, he was responsible for a $530 million portfolio of lens, lens care and OTC pharmaceuticals. Jeff brings a wealth of marketing and management experience to our Company and we believe he will be a very strong contributor to Solta." Mr. Nardoci spent 11 years at Bausch & Lomb in increasingly responsible positions. Prior to Bausch & Lomb, he was an executive consultant at Meridian Euro RSCG, a sales and marketing consulting group. His experience also includes seven years at Nabisco in the specialty foods marketing organization. Mr. Nardoci has a B.A. in Economics from Fairleigh Dickinson University. "This is a very exciting time to join Solta Medical," said Mr. Nardoci. "The Company has established itself as a well-respected, innovative leader in the aesthetics industry and is poised for continued growth. There are significant opportunities to extend awareness of the company's Thermage® and Fraxel® brands, implement new marketing programs and help drive sales. I look forward to working with the entire Solta team." ABOUT SOLTA MEDICAL Solta Medical is a global leader in the medical aesthetics market providing innovative, safe and effective anti-aging solutions for patients that enhance and expand the practice of medical aesthetics for physicians. The company offers products to address aging skin under the industry's two premier brands: Thermage® and Fraxel®. Thermage is an innovative, non-invasive radiofrequency procedure for tightening and contouring skin. As the leader in fractional laser technology, Fraxel delivers minimally invasive clinical solutions to resurface aging and sun damaged skin. Since 2002, over one million Thermage and Fraxel procedures have been performed in nearly 80 countries. Thermage and Fraxel are the perfect complement for any aesthetic practice. For more information about Solta Medical, call 1-877-782-2286 or log on to http://www.solta.com/. DATASOURCE: Solta Medical, Inc. CONTACT: Jack Glenn, Chief Financial Officer of Solta Medical, Inc., +1-510-786-6890 Web Site: http://www.solta.com/

Copyright